These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11468243)

  • 1. Immuno-PCR assay for homodimeric osteoprotegerin.
    Furuya D; Kaneko R; Yagihashi A; Endoh T; Yajima T; Kobayashi D; Yano K; Tsuda E; Watanabe N
    Clin Chem; 2001 Aug; 47(8):1475-7. PubMed ID: 11468243
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological study on circulating murine osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF): possible role of OPG/OCIF in the prevention of osteoporosis in pregnancy.
    Yano K; Shibata O; Mizuno A; Kobayashi F; Higashio K; Morinaga T; Tsuda E
    Biochem Biophys Res Commun; 2001 Oct; 288(1):217-24. PubMed ID: 11594776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteoprotegerin (OPG)].
    Takahashi N; Kimura H; Yoshida H
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():818-20. PubMed ID: 16149650
    [No Abstract]   [Full Text] [Related]  

  • 4. ELISA methodology for detection of modified osteoprotegerin in clinical studies.
    Chen D; Sarikaya NA; Gunn H; Martin SW; Young JD
    Clin Chem; 2001 Apr; 47(4):747-9. PubMed ID: 11274028
    [No Abstract]   [Full Text] [Related]  

  • 5. Correspondence re: A. Lipton et al., Serum osteoprotegerin levels in healthy controls and cancer patients. Clin. Cancer Res., 8: 2306-2310, 2002.
    Dovio A; Sartori ML; Angeli A
    Clin Cancer Res; 2003 Jun; 9(6):2384-5; author reply 2386. PubMed ID: 12796409
    [No Abstract]   [Full Text] [Related]  

  • 6. No change in circulating osteoprotegerin levels by intravenous calcitriol therapy among dialysis patients with secondary hyperparathyroidism.
    Nishi H; Nii-Kono T; Ikeda K; Fujimori A; Fukagawa M
    Clin Nephrol; 2006 Feb; 65(2):149-50. PubMed ID: 16509469
    [No Abstract]   [Full Text] [Related]  

  • 7. [Osteoclast-activating factors (OAF)].
    Sato K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():228-31. PubMed ID: 15658306
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls.
    Corso A; Dovio A; Rusconi C; Sartori ML; Klersy C; Varettoni M; Mangiacavalli S; Zappasodi P; Ventura M; Angeli A; Lazzarino M
    Leukemia; 2004 Sep; 18(9):1555-7. PubMed ID: 15241438
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.
    Vegni FE; Corradini C; Privitera G
    N Engl J Med; 2004 Jan; 350(2):189-92; author reply 189-92. PubMed ID: 14711922
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis.
    Sasaki N; Kusano E; Ando Y; Yano K; Tsuda E; Asano Y
    Nephrol Dial Transplant; 2001 Mar; 16(3):479-82. PubMed ID: 11239019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis.
    Yano K; Tsuda E; Washida N; Kobayashi F; Goto M; Harada A; Ikeda K; Higashio K; Yamada Y
    J Bone Miner Res; 1999 Apr; 14(4):518-27. PubMed ID: 10234572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating osteoprotegerin is not removed through haemodialysis membrane.
    Kazama JJ; Kato H; Sato T; Shigematsu T; Fukagawa M; Iwasaki Y; Gejyo F
    Nephrol Dial Transplant; 2002 Oct; 17(10):1860-1. PubMed ID: 12271009
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation and prognostic value of serum osteoprotegerin in multiple myeloma.
    Depil S; Mathiot C; Leleu X; Moreau AS; Faucompré JL; Hennache B; Bauters F; Bataille R; Facon T
    Br J Haematol; 2005 Jun; 129(5):706-7. PubMed ID: 15916694
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased serum osteoprotegerin level in older and diabetic hemodialysis patients.
    Doi S; Yorioka N; Masaki T; Ito T; Shigemoto K; Harada S
    Ther Apher Dial; 2004 Aug; 8(4):335-9. PubMed ID: 15274686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis.
    Schoppet M; Sattler AM; Schaefer JR; Hofbauer LC
    Atherosclerosis; 2006 Feb; 184(2):446-7. PubMed ID: 16325821
    [No Abstract]   [Full Text] [Related]  

  • 16. Skeleton key to vascular disease.
    Demer LL; Abedin M
    J Am Coll Cardiol; 2004 Nov; 44(10):1977-9. PubMed ID: 15542279
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males.
    Oh KW; Rhee EJ; Lee WY; Kim SW; Baek KH; Kang MI; Yun EJ; Park CY; Ihm SH; Choi MG; Yoo HJ; Park SW
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):92-8. PubMed ID: 15638876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased osteoprotegerin and decreased pyridinoline levels in patients with ankylosing spondylitis: comment on the article by Gratacós et al.
    Golmia RP; Sousa BD; Scheinberg MA
    Arthritis Rheum; 2002 Dec; 46(12):3390-1; author reply 3392. PubMed ID: 12483748
    [No Abstract]   [Full Text] [Related]  

  • 19. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.
    Ziolkowska M; Kurowska M; Radzikowska A; Luszczykiewicz G; Wiland P; Dziewczopolski W; Filipowicz-Sosnowska A; Pazdur J; Szechinski J; Kowalczewski J; Rell-Bakalarska M; Maslinski W
    Arthritis Rheum; 2002 Jul; 46(7):1744-53. PubMed ID: 12124857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancer.
    Jung K; Lein M; von Hösslin K; Brux B; Schnorr D; Loening SA; Sinha P
    Clin Chem; 2001 Nov; 47(11):2061-3. PubMed ID: 11673385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.